Top Markets
Coin of the day
Harpoon Therapeutics, Inc. Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc.

HARP
Classifica tra le azioni #23352
Harpoon Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Harpoon Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to immunotherapy, focused on engineering a novel class of T cell activators. These therapies are designed to leverage the body's own immune system to fight cancer and other diseases in patients across the United States. The company's innovative Tri-specific T cell activating construct (TriTAC) platform forms the basis of its development pipeline. This includes HPN328, currently undergoing Phase I/II clinical trials for small cell lung cancer and tumors that express Delta-like canonical Notch ligand 3; HPN217, also in Phase I/II trials for the treatment of multiple myeloma; and HPN536, which is in Phase I/IIa clinical evaluation for ovarian and pancreatic cancers, alongside other mesothelin-expressing tumors. Furthermore, Harpoon has a preclinical asset, HPN601, aimed at various solid tumor indications. The company has also established a discovery collaboration and licensing agreement with AbbVie Biotechnology Ltd. to develop and market products combining its unique TriTAC technology with soluble T cell receptors. Founded in 2015, Harpoon Therapeutics, Inc. is headquartered in South San Francisco, California.
Prezzo delle azioni
$23.01
Ultima sincronizzazione: 2024-03-11
Capitalizzazione di mercato
$74.80M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Harpoon Therapeutics, Inc. (HARP)

Categoria

Storico del prezzo dell'azione per Harpoon Therapeutics, Inc. (HARP)
Prezzo di chiusura più alto: $22.98 il 2024-03-01

Prezzo di chiusura più basso: $146.51 il 2019-02-01
Storico del prezzo dell'azione di Harpoon Therapeutics, Inc. dal 2019 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 118.66%
2023 37.41%
2022 -88.70%
2021 -54.80%
2020 -14.80%
2019 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH